Initially Ocimum will perform Gene Expression studies on the Affymetrix platform but within a couple of months will launch its entire portfolio of services.
The move into the European market is part of the company’s strategy to have a network of service centers in close proximity to leading genomics researchers.
Anu Acharya, CEO of Ocimum and Gene Logic, said: “With the introduction of Affymetrix based genomics services in Europe, we are now available at the doorsteps of leading lifescience companies and research centers in Europe.”